<DOC>
	<DOCNO>NCT00537082</DOCNO>
	<brief_summary>To provide efficacy safety data two dos ( 0.5 mg 1.25 mg ) FTY720 Japanese patient relapse multiple sclerosis ( MS )</brief_summary>
	<brief_title>Efficacy Safety FTY720 Patients With Relapsing Multiple Sclerosis ( MS )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Male female patient aged 1860 Patients diagnosis multiple sclerosis Patients history presence chronic disease immune system MS Patients history presence malignancy , pulmonary heart disease , etc . Pregnant nursing ( lactate ) woman Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>FTY720 ,</keyword>
	<keyword>MS</keyword>
</DOC>